Childen's Hospital Boston
International Visitorsdotted lineRequest Appointmentdotted lineDirections
 advanced search
About Us Find a Specialist Locations Careers Press Room Giving To
Clinical Services For Patients & Families For Health Professionals Research
My Child Has
or find by letter:  A-F  G-L  M-R  S-Z
Find a Specialist
 X
Printer Friendly

Mark W. Kieran, MD, PhD

 Previous | Next  | Return to Search Results

Departments/Divisions
Hematology/Oncology
Medicine

Specialties
anti-angiogenesis
brain tumors
neuro-oncology
oncology

Services/Programs
Brain Tumor Program
Oncology

Clinical Title
Director, Pediatric Medical Neuro-Oncology

Academic Appointment
Associate Professor of Pediatrics, Harvard Medical School

Board Certification(s)
Pediatrics, Pediatric Hematology/Oncology

 

Professional History
 
Medical/Dental School
University of Calgary Faculty of Medicine, CANADA (1986)

Residency
Pediatrics, Montreal Children's Hospital, McGill University, Quebec, CANADA (07/89 to 06/92)

Fellowship
Children's Hospital Boston/Dana Farber Cancer Institute, Boston, MA (07/92 to 06/95)

Research Activities

  • Research site for Mark Kieran, MD, PhD
     
  • Neuro-oncology
    • Therapy of pediatric brain tumors ( J Clin Oncol 19:480, 2001; Pediatr Hematol Oncol 20:497, 2003; J Clin Oncol 23:525, 2005)
    • Antiangiogenic therapy of brain tumors (Nature Medicine 9:1104, 2003; J Neurooncol 75:327, 2005; J Pediatr Hematol Oncol 27:573, 2005; Clin Cancer Res 11:8145, 2005)
    • Novel techniques for imaging brain tumors (Magn Reson Med 51:893, 2004; NMR Biomed 17:399, 2004)
    • Psychosocial and behavioral functioning among pediatric brain tumor survivors. (J Neurooncol 63:279, 2003; Pediatr Neurol 34:13, 2006)
    • Complications of brain tumor therapy (Pediatr Neurol 35:122, 2006)
    • Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol. 2008 Sep;67(9):911-20.
    • Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells. Neuro Oncol. 2008 Aug 5.
    • Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy. J Neurooncol. 2008 Aug;89(1):89-95.
    • Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007. Am J Med Genet A. 2008 May 1;146A(9):1205-17.
    • Remission of infantile generalized myofibromatosis after interferon alpha therapy. J Pediatr Hematol Oncol. 2008 Feb;30(2):179-81.

  •  Previous | Next  | Return to Search Results




    Mark W. Kieran, MD, PhD  
       

    Contact Information

    Primary Office Location
    Dana-Farber Cancer Institute
    Department of Pediatric Oncology
    44 Binney Street
    Boston, MA  02115
    View Map
    Driving Directions

    Phone: 617-632-4386
    Fax: 617-632-4897
    E-mail

    Other Office Location
    Children's Hospital Boston


    Expanded Biography

    Professional History

    Contact Us Privacy Accessibility Give Now